LBRX
LB PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$40.15
+0.80%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-25.8%
Return on equity
-23.7%
Return on assets
-28.2%
Return on invested capital
0.00x
Asset turnover
-$82.4M
Cash from operations
$10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026